Quest Diagnostics Incorporated (LON:0KSX)
165.35
-2.41 (-1.43%)
At close: Jul 15, 2025
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.65B USD in the quarter ending March 31, 2025, with 12.09% growth. This brings the company's revenue in the last twelve months to $10.16B, up 9.38% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.16B
Revenue Growth
+9.38%
P/S Ratio
1.76
Revenue / Employee
$181.39K
Employees
56,000
Market Cap
13.87B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Quest Diagnostics News
- 21 days ago - Woman (54) with terminal cervical cancer settles case over smear tests - The Irish Times
- 21 days ago - Quest Diagnostics Releases 2024 Corporate Responsibility Report - PRNewsWire
- 23 days ago - Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 - PRNewsWire
- 26 days ago - Quest Diagnostics Stock Trades Near A Buy Zone; Capture Profits With This Long Call Butterfly In Options Trading - Investor's Business Daily
- 5 weeks ago - Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology - PRNewsWire
- 6 weeks ago - Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga
- 2 months ago - More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals - PRNewsWire
- 2 months ago - $1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga